Published on
October 1, 2022
- 16:06 GMT
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc of 492M USD
The deal's total amount set a record high, for the out-licensing of preclinical autoimmune assets in China. Simcere (2096.HK:2096.HK) NANJING, JIANGSU, CHINA, October 1, 2022 /EINPresswire.com/ -- Simcere Pharmaceutical Group（2096.HK), an …
Distribution channels:
Business & Economy, Companies
...
